NO20030393D0 - Effektiv ligand-mediert Ullmann-kobling av aniliner og azoler - Google Patents
Effektiv ligand-mediert Ullmann-kobling av aniliner og azolerInfo
- Publication number
- NO20030393D0 NO20030393D0 NO20030393A NO20030393A NO20030393D0 NO 20030393 D0 NO20030393 D0 NO 20030393D0 NO 20030393 A NO20030393 A NO 20030393A NO 20030393 A NO20030393 A NO 20030393A NO 20030393 D0 NO20030393 D0 NO 20030393D0
- Authority
- NO
- Norway
- Prior art keywords
- azoles
- anilines
- ullmann coupling
- efficient ligand
- mediated ullmann
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Executing Machine-Instructions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22093200P | 2000-07-26 | 2000-07-26 | |
| PCT/US2001/023541 WO2002008199A2 (en) | 2000-07-26 | 2001-07-26 | Efficient ligand-mediated ullmann coupling of anilines and azoles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030393D0 true NO20030393D0 (no) | 2003-01-24 |
| NO20030393L NO20030393L (no) | 2003-03-24 |
Family
ID=22825611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030393A NO20030393L (no) | 2000-07-26 | 2003-01-24 | Effektiv ligand-mediert Ullmann-kobling av aniliner og azoler |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6541639B2 (no) |
| EP (1) | EP1307431B1 (no) |
| JP (1) | JP2004504384A (no) |
| KR (1) | KR20030060872A (no) |
| CN (1) | CN1444565A (no) |
| AT (1) | ATE307804T1 (no) |
| AU (1) | AU2001280813A1 (no) |
| BR (1) | BR0112746A (no) |
| CA (1) | CA2417426A1 (no) |
| DE (1) | DE60114424T2 (no) |
| EC (1) | ECSP034453A (no) |
| ES (1) | ES2251501T3 (no) |
| HU (1) | HUP0301699A3 (no) |
| IL (1) | IL153547A0 (no) |
| IS (1) | IS6695A (no) |
| MX (1) | MXPA03000686A (no) |
| NO (1) | NO20030393L (no) |
| NZ (1) | NZ523271A (no) |
| PL (1) | PL361233A1 (no) |
| RU (1) | RU2003103706A (no) |
| WO (1) | WO2002008199A2 (no) |
| ZA (1) | ZA200300039B (no) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7361678B2 (en) * | 2002-03-05 | 2008-04-22 | Transtech Pharma, Inc. | Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| US6759554B2 (en) * | 2001-04-24 | 2004-07-06 | Massachusetts Institute Of Technology | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| AU2003255620A1 (en) * | 2002-05-31 | 2003-12-19 | Rhodia Chimie | Method of forming a carbon-carbon or carbon-heteroatom linkage |
| JP2005534700A (ja) | 2002-08-02 | 2005-11-17 | マサチューセッツ インスティテュート オブ テクノロジー | 銅触媒による炭素−ヘテロ原子および炭素−炭素結合の形成 |
| US20040067995A1 (en) * | 2002-10-02 | 2004-04-08 | Wong Pancras C. | Novel combination of a factor Xa inhibitor and clopidogrel |
| EP1635823A1 (en) * | 2003-05-20 | 2006-03-22 | TransTech Pharma Inc. | Rage antagonists as agents to reverse amyloidosis and diseases associated therewith |
| CN1984872A (zh) * | 2004-07-16 | 2007-06-20 | 帝斯曼知识产权资产管理有限公司 | 制备（杂）芳胺的方法 |
| KR102065319B1 (ko) | 2007-03-12 | 2020-01-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치환된 헤테로환 융합 감마-카르볼린 합성 |
| ES2467923T3 (es) | 2009-09-30 | 2014-06-13 | Transtech Pharma, Llc | Derivados de imidazol substituidos para el tratamiento de la enfermedad de Alzheimer |
| US20150080404A1 (en) | 2012-04-14 | 2015-03-19 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
| WO2014145192A1 (en) | 2013-03-15 | 2014-09-18 | Intra-Cellular Therapies, Inc. | Organic compounds |
| PL3076967T3 (pl) | 2013-12-03 | 2021-12-20 | Intra-Cellular Therapies, Inc. | Metody leczenia objawów rezydualnych schizofrenii |
| EP3125892A4 (en) | 2014-04-04 | 2017-12-27 | Intra-Cellular Therapies, Inc. | Organic compounds |
| MX388258B (es) | 2014-04-04 | 2025-03-19 | Intra Cellular Therapies Inc | Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio. |
| WO2015171951A1 (en) * | 2014-05-07 | 2015-11-12 | The Regents Of The University Of Colorado, A Body Corporate | 2-(4-aryl-1h-imidazol-1-yl)aniline compounds |
| HUE053737T2 (hu) | 2016-01-26 | 2021-07-28 | Intra Cellular Therapies Inc | Piridopirrolokinoxalin vegyületek, készítményeik és alkalmazásaik |
| PL3407889T3 (pl) | 2016-03-25 | 2021-11-22 | Intra-Cellular Therapies, Inc. | Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego |
| EP3436016B1 (en) | 2016-03-28 | 2022-04-27 | Intra-Cellular Therapies, Inc. | Novel co-crystals |
| JP2019513143A (ja) | 2016-03-28 | 2019-05-23 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 新規塩類および結晶 |
| WO2017172795A1 (en) | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
| US11331316B2 (en) | 2016-10-12 | 2022-05-17 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| JP6987868B2 (ja) | 2016-12-29 | 2022-01-05 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 有機化合物 |
| WO2018126140A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20240141212A (ko) | 2017-03-24 | 2024-09-25 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 조성물 및 방법 |
| AU2018307480B2 (en) | 2017-07-26 | 2023-11-23 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2019023062A1 (en) | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
| CR20200464A (es) | 2018-03-08 | 2021-04-14 | Incyte Corp | Compuestos diólicos de aminopirazina como inhibidores de pi3k-y |
| CN112040940A (zh) | 2018-03-23 | 2020-12-04 | 细胞内治疗公司 | 有机化合物 |
| JP7476115B2 (ja) | 2018-06-06 | 2024-04-30 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 新規の塩および結晶 |
| EP3801527B1 (en) | 2018-06-08 | 2025-02-19 | Intra-Cellular Therapies, Inc. | Fused gamma-carbolines for acute treatment of anxiety or depression |
| JP7483671B2 (ja) | 2018-06-11 | 2024-05-15 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 置換ヘテロ環縮合ガンマ－カルボリン類合成 |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
| EP3843729A4 (en) | 2018-08-29 | 2022-06-01 | Intra-Cellular Therapies, Inc. | NEW COMPOSITIONS AND METHODS |
| WO2020047407A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| CN118873536A (zh) | 2018-08-31 | 2024-11-01 | 细胞内治疗公司 | 新方法 |
| AU2019387370A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| WO2020131911A1 (en) | 2018-12-17 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines synthesis |
| AU2019403149B2 (en) | 2018-12-17 | 2025-04-03 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines synthesis |
| EP4134101A1 (en) | 2019-07-07 | 2023-02-15 | Intra-Cellular Therapies, Inc. | Deuterated lumateperone for the treatment of the bipolar ii disorder |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6372658A (ja) | 1986-09-17 | 1988-04-02 | Sumitomo Chem Co Ltd | ニトロジフエニルアミン類の製造方法 |
| US5705697A (en) | 1997-01-30 | 1998-01-06 | Xerox Corporation | Arylamine processes |
| ZA985247B (en) | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
-
2001
- 2001-07-25 US US09/912,950 patent/US6541639B2/en not_active Expired - Fee Related
- 2001-07-26 EP EP01959231A patent/EP1307431B1/en not_active Expired - Lifetime
- 2001-07-26 AU AU2001280813A patent/AU2001280813A1/en not_active Abandoned
- 2001-07-26 AT AT01959231T patent/ATE307804T1/de not_active IP Right Cessation
- 2001-07-26 NZ NZ523271A patent/NZ523271A/en unknown
- 2001-07-26 CN CN01813378A patent/CN1444565A/zh active Pending
- 2001-07-26 IL IL15354701A patent/IL153547A0/xx unknown
- 2001-07-26 DE DE60114424T patent/DE60114424T2/de not_active Expired - Fee Related
- 2001-07-26 BR BR0112746-2A patent/BR0112746A/pt not_active IP Right Cessation
- 2001-07-26 ES ES01959231T patent/ES2251501T3/es not_active Expired - Lifetime
- 2001-07-26 WO PCT/US2001/023541 patent/WO2002008199A2/en not_active Ceased
- 2001-07-26 HU HU0301699A patent/HUP0301699A3/hu unknown
- 2001-07-26 CA CA002417426A patent/CA2417426A1/en not_active Abandoned
- 2001-07-26 JP JP2002514105A patent/JP2004504384A/ja active Pending
- 2001-07-26 RU RU2003103706/04A patent/RU2003103706A/ru not_active Application Discontinuation
- 2001-07-26 KR KR10-2003-7001155A patent/KR20030060872A/ko not_active Withdrawn
- 2001-07-26 MX MXPA03000686A patent/MXPA03000686A/es unknown
- 2001-07-26 PL PL36123301A patent/PL361233A1/xx not_active Application Discontinuation
-
2003
- 2003-01-02 ZA ZA200300039A patent/ZA200300039B/en unknown
- 2003-01-22 IS IS6695A patent/IS6695A/is unknown
- 2003-01-24 EC EC2003004453A patent/ECSP034453A/es unknown
- 2003-01-24 NO NO20030393A patent/NO20030393L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1307431A2 (en) | 2003-05-07 |
| HUP0301699A3 (en) | 2004-03-29 |
| ES2251501T3 (es) | 2006-05-01 |
| IL153547A0 (en) | 2003-07-06 |
| ZA200300039B (en) | 2004-04-02 |
| IS6695A (is) | 2003-01-22 |
| KR20030060872A (ko) | 2003-07-16 |
| CA2417426A1 (en) | 2002-01-31 |
| US20020099225A1 (en) | 2002-07-25 |
| DE60114424D1 (de) | 2005-12-01 |
| WO2002008199A3 (en) | 2002-06-13 |
| AU2001280813A1 (en) | 2002-02-05 |
| MXPA03000686A (es) | 2003-06-06 |
| CN1444565A (zh) | 2003-09-24 |
| ECSP034453A (es) | 2003-03-31 |
| HUP0301699A2 (hu) | 2003-12-29 |
| DE60114424T2 (de) | 2006-07-27 |
| RU2003103706A (ru) | 2004-08-10 |
| US6541639B2 (en) | 2003-04-01 |
| JP2004504384A (ja) | 2004-02-12 |
| EP1307431B1 (en) | 2005-10-26 |
| PL361233A1 (en) | 2004-10-04 |
| WO2002008199A2 (en) | 2002-01-31 |
| NO20030393L (no) | 2003-03-24 |
| ATE307804T1 (de) | 2005-11-15 |
| NZ523271A (en) | 2005-01-28 |
| BR0112746A (pt) | 2003-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030393D0 (no) | Effektiv ligand-mediert Ullmann-kobling av aniliner og azoler | |
| PT1131318E (pt) | Processo para a producao de pirazoles 5-substituidos utilizando ditietanos | |
| PL372799A1 (en) | New compounds | |
| EE05015B1 (et) | Makseterminaliseade mgipunktiseadme hendamiseks, maksessteem ja makseprotseduuri teostamise meetod | |
| GB0130341D0 (en) | Compounds | |
| DE60120494D1 (de) | Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren | |
| IL139080A0 (en) | Btx inhibitors and methods for their indentification and use | |
| TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
| EP1583603A4 (en) | WATER-SOLUBLE PRODUCTS AND METHODS OF MAKING AND USING THE SAME | |
| IL161966A0 (en) | Aryloxyphenyl and arylsulfanylphenyl | |
| CY1112442T1 (el) | Παραγωγα πυριδινονης για θεραπεια αθηροσκληρωσης | |
| EA200001129A3 (ru) | Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина | |
| MY137541A (en) | Polymerization catalyst activators, method of preparing, and their use in polymerization processes | |
| GB0011358D0 (en) | Novel use | |
| AU2003290592A1 (en) | Antitumor benzoylsulfonamides | |
| IT1311813B1 (it) | Procedimento ed apparecchiatura per la fabbricazione di lastre inmateriale lapideo. | |
| AR022321A1 (es) | Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| NO20033921L (no) | Inhibitor av monoaminopptak | |
| IS2273B (is) | Aðferð fyrir nýsmíðina á HIV próteasa lötum | |
| NO20006205L (no) | Morfin-6-glukuronidsyntese | |
| DE60207833D1 (de) | Peptiddeformylase-hemmer | |
| PT1387837E (pt) | Novos derivados de azole e de triazole, processo para a sua preparacao e sua aplicacao como medicamentos anti-fungicos | |
| AU2003304490A1 (en) | Peptide deformylase inhibitors | |
| MXPA04004526A (es) | N-metil-homocisteinas, su uso y metodo para su produccion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |